- BRAF inhibitors: efficacious and tolerable in BRAF-mutant acral and m…
Number of the records: 1  

BRAF inhibitors: efficacious and tolerable in BRAF-mutant acral and mucosal melanoma

  1. TitleBRAF inhibitors: efficacious and tolerable in BRAF-mutant acral and mucosal melanoma / X. Bai ... [et al.]
    Another responsib. Bai, X. (Author)
    Translated titleBRAF inhibítory: účinné a prijateľné pri akrálnom a slizničnom melanóme s BRAF-mutáciou
    Phys.des.ilustr., grafy, tab.
    NoteBibliogr. odkazy. Res. angl.
    In Neoplasma. -- ISSN 0028-2685. -- Vol. 64, no. 4 (2017), s. 626-632
    Call numberC 720
    MeSH Subject melanóm - farmakoterapia - genetika
    nádory kože - farmakoterapia - genetika
    proteíny protoonkogénové B-raf - antagonisty a inhibítory - použitie terapeutické - účinky nežiaduce
    metastázy nádorové
    výsledok liečby
    analýza prežívania
    Keywords sorafenib * vemurafenib
    LanguageEnglish
    CountrySlovakia
    DatabaseARTICLES
    article

    article

Number of the records: 1  

  This site uses cookies to make them easier to browse. Learn more about how we use cookies.